Nemera’s holistic approach to dermal drug delivery
January 26, 2021Read moreThe latest issue of ‘Skin Drug Delivery’ is highlighted Nemera’s holistic approach in dermal pharmaceutical application.
A new statistical method to assess in vitro bioequivalence of nasal products
January 20, 2021Read moreThis article presents the so called Between-Batch Bioequivalence (BBE) method, evaluated through both simulation and real-case (Nasonex® & Flonase®) studies.
Safe’n’Sound®: Protection against needlestick injuries
January 6, 2021Read moreThe latest issue of ‘Harro Höfliger’ is highlighted Safe’n’Sound, our parenteral passive safety device. Read more…
Our preservative-free ophthalmic device is highlighted in ‘The Pharmaceutical Post’ magazine
December 17, 2020Read moreThe latest issue of ‘The Pharmaceutical Post’ is highlighting Ophthalmic Preservative-free devices. Read more…
Nemera announces the appointment of Véronique Kodjo as non-Executive member of the Board
December 14, 2020Read moreNemera, today announced the appointment of senior leader Véronique Kodjo as a non-Executive member of its Board. She will work closely with the Chief Operating Officer and senior leadership to accompany Nemera on its journey toward operational excellence.
